GUTS

Fractyl Health, Inc. Common Stock (GUTS)

US
$ 1.41-10.19%

Price Chart

Key Statistics

Market Cap
$ 106.28M
P/E Ratio
0.00
Revenue (TTM)
$ 60K
Volume
257.14K
52W High
$ 5.74
52W Low
$ 0.87
Dividend Yield
0.00%
Beta
0.00

Technicals

50-Day MA
1.577
200-Day MA
1.9934
52 Week High
5.74
52 Week Low
0.873

About GUTS

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.

Employees
109
Headquarters
Burlington, MA
CEO
Dr. Harith Rajagopalan M.D., Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg